Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 59 (11) , 1006-1020
- https://doi.org/10.1016/j.biopsych.2005.10.021
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic DrugsNeuropsychopharmacology, 2005
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiologyMolecular Psychiatry, 2004
- Neuropeptide systems as novel therapeutic targets for depression and anxiety disordersTrends in Pharmacological Sciences, 2003
- In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3Neuropsychopharmacology, 2003
- Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotectionJournal of Neuroscience Research, 2000
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neuronsSynapse, 1996
- A question of reliabilityNature, 1994
- NMDA and quisqualate reduce a Ca-dependent K+ current by a protein kinase-mediated mechanismNeuroscience Letters, 1990